| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders
|
Vervloet, Marc G
|
|
2014
|
2 |
5 |
p. 427-436
10 p.
|
article
|
| 2 |
Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study
|
Di Dalmazi, Guido
|
|
2014
|
2 |
5 |
p. 396-405
10 p.
|
article
|
| 3 |
Correction for Lancet Diabetes Endocrinol 2014; published online April 8
|
|
|
2014
|
2 |
5 |
p. e12-
1 p.
|
article
|
| 4 |
Correction for Lancet Diabetes Endocrinol 2014; published online March 25
|
|
|
2014
|
2 |
5 |
p. e12-
1 p.
|
article
|
| 5 |
Definition and management of radioactive iodine-refractory differentiated thyroid cancer
|
Schlumberger, Martin
|
|
2014
|
2 |
5 |
p. 356-358
3 p.
|
article
|
| 6 |
Dreaming of normoglycaemia with fewer diet restrictions
|
Ruggenenti, Piero
|
|
2014
|
2 |
5 |
p. 350-351
2 p.
|
article
|
| 7 |
Effects of sodium restriction and hydrochlorothiazide on RAAS blockade efficacy in diabetic nephropathy: a randomised clinical trial
|
Kwakernaak, Arjan J
|
|
2014
|
2 |
5 |
p. 385-395
11 p.
|
article
|
| 8 |
Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial
|
Barnett, Anthony H
|
|
2014
|
2 |
5 |
p. 369-384
16 p.
|
article
|
| 9 |
Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease
|
de Vries, Aiko P J
|
|
2014
|
2 |
5 |
p. 417-426
10 p.
|
article
|
| 10 |
Giovanni Strippoli: finding the pleasures in nephrology
|
Burki, Talha Khan
|
|
2014
|
2 |
5 |
p. 367-
1 p.
|
article
|
| 11 |
How should patients with adrenal incidentalomas be followed up?
|
Pivonello, Rosario
|
|
2014
|
2 |
5 |
p. 352-354
3 p.
|
article
|
| 12 |
How to create yourself
|
Cantor, Abi
|
|
2014
|
2 |
5 |
p. 368-
1 p.
|
article
|
| 13 |
Implantable insulin pumps: an effective option with restricted dissemination
|
Spaan, Nienke A
|
|
2014
|
2 |
5 |
p. 358-360
3 p.
|
article
|
| 14 |
Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial
|
Stefan, Norbert
|
|
2014
|
2 |
5 |
p. 406-416
11 p.
|
article
|
| 15 |
Kidney failure: are we failing?
|
The Lancet Diabetes & Endocrinology,
|
|
2014
|
2 |
5 |
p. 349-
1 p.
|
article
|
| 16 |
Research in brief
|
Kang, Seema
|
|
2014
|
2 |
5 |
p. 366-
1 p.
|
article
|
| 17 |
Salt, hypertension, and proteinuria in diabetic nephropathy
|
Weir, Matthew R
|
|
2014
|
2 |
5 |
p. 351-352
2 p.
|
article
|
| 18 |
Subclinical Cushing's syndrome and cardiovascular disease
|
Anagnostis, Panagiotis
|
|
2014
|
2 |
5 |
p. 361-
1 p.
|
article
|
| 19 |
Targeting non-alcoholic fatty liver disease through 11-βHSD1 inhibition
|
Ratziu, Vlad
|
|
2014
|
2 |
5 |
p. 354-356
3 p.
|
article
|
| 20 |
The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes
|
Grant, William B
|
|
2014
|
2 |
5 |
p. 364-
1 p.
|
article
|
| 21 |
The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes
|
Bischoff-Ferrari, Heike A
|
|
2014
|
2 |
5 |
p. 363-364
2 p.
|
article
|
| 22 |
The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes
|
Anagnostis, Panagiotis
|
|
2014
|
2 |
5 |
p. 362-363
2 p.
|
article
|
| 23 |
The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes – Authors' reply
|
Bolland, Mark J
|
|
2014
|
2 |
5 |
p. 364-365
2 p.
|
article
|
| 24 |
Vitamin D, obesity, and risk of diabetes
|
Boucher, Barbara
|
|
2014
|
2 |
5 |
p. 361-362
2 p.
|
article
|
Journal description